There is no consensus treatment for patients with autoimmune hepatitis (AIH) - primary biliary cholangitis (PBC) overlap syndrome who are not responding to conventional therapy. We present a case of a 43-yr-old woman with AIH-PBC overlap syndrome treated with obeticholic acid (OCA). The patient showed a reduction in liver enzymes and no fibrosis progression during 15 months of follow up.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.17235/reed.2020.6883/2020 | DOI Listing |
Publication Analysis
Top Keywords
overlap syndrome
12
biliary cholangitis
8
obeticholic acid
8
effective treatment
4
treatment autoimmune
4
autoimmune hepatitis-primary
4
hepatitis-primary biliary
4
cholangitis overlap
4
syndrome obeticholic
4
acid consensus
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!